Lee Schacter
- Otorhinolaryngology top 1%
- Oncology top 5%
- Lung Cancer Research Studies 10
- Cancer Treatment and Pharmacology 4
- Genetics top 5%
- Hematology top 5%
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances 8
-
- Cancer therapeutics and mechanisms 10
- Glutathione Transferases and Polymorphisms 4
-
- Lung Cancer Treatments and Mutations 5
-
- Testicular diseases and treatments 4
-
- Lymphoma Diagnosis and Treatment 4
- Co-authors
- Lawrence H. EinhornK. S. SridharE Vélez-GarcíaGary H. LymanL H EinhornCharlotte JacobsJoanne MortimerLawrence T. Goodnough
- Cited by
- OtorhinolaryngologyOncologyGenetics
- Journals
- Journal of Clinical Oncology (7 papers)Biochemical and Biophysical Research Communications (3 papers)Investigational New Drugs (2 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Lee Schacter
45 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Otorhinolaryngology 342
- Oncology 927
- Genetics 221
- Hematology 232
- Epidemiology 477
Countries citing papers authored by Lee Schacter
This map shows the geographic impact of Lee Schacter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Schacter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Schacter more than expected).
Fields of papers citing papers by Lee Schacter
This network shows the impact of papers produced by Lee Schacter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Schacter. The network helps show where Lee Schacter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lee Schacter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 25 | |
| 2 | ACT/DB: A Clinical Trials Database Being Refined on a Pilot Basis at Two Medical Centers | 1998 | 1 |
| 3 | 1998 | 80 | |
| 4 | 1997 | 15 | |
| 5 | 1996 | 23 | |
| 6 | 1996 | 10 | |
| 7 | 1996 | 11 | |
| 8 | 1995 | 20 | |
| 9 | 1995 | 9 | |
| 10 | 1994 | 19 | |
| 11 | 1994 | 7 | |
| 12 | 1992 | 406 | |
| 13 | A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.breakdown → | 1992 | 465 |
| 14 | 1991 | 204 | |
| 15 | Overview of hormonal therapy in advanced breast cancer. | 1990 | 23 |
| 16 | 1990 | 49 | |
| 17 | 1989 | 45 | |
| 18 | 1988 | 42 | |
| 19 | 1986 | 12 | |
| 20 | 1985 | 34 |
About Lee Schacter
Lee Schacter is a scholar working on Oncology, Genetics and Reproductive Medicine, having authored 45 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (10 papers), Lung Cancer Research Studies (10 papers), Neuroendocrine Tumor Research Advances (8 papers), Lung Cancer Treatments and Mutations (5 papers), Testicular diseases and treatments (4 papers), Glutathione Transferases and Polymorphisms (4 papers), Cancer Treatment and Pharmacology (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Otorhinolaryngology (342 citations), Oncology (927 citations) and Genetics (221 citations). Lee Schacter has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Lawrence H. Einhorn, K. S. Sridhar, E Vélez-García, Gary H. Lyman, L H Einhorn, Charlotte Jacobs, Joanne Mortimer, Lawrence T. Goodnough, Howard S. Höchster and W. Andy Knight. Their work appears in journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications, Investigational New Drugs, Cancer and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.